Table 1

Comparison of demographics between gastric disease with Helicobacter pylori eradication and controls

ControlEarly eradicationLate eradicationEradication, overall
n=26 944 (%)n=3062 (%)n=3674 (%)n=6736 (%)P value
Age, years0.99
≤4911 432 (42.4)1616 (52.8)1242 (33.8)2858 (42.4)
50–659544 (35.4)986 (32.2)1400 (38.1)2386 (35.4)
≥655968 (22.2)460 (15.0)1032 (28.1)1492 (22.2)
Mean (SD)*52.6 (14.9)49.5 (14.1)56.0 (14.3)53.0 (14.6)0.01
Sex0.99
Female12 128 (45.0)1243 (40.6)1789 (48.7)3032 (45.0)
Male14 816 (55.0)1819 (59.4)1885 (51.3)3704 (55.0)
Comorbidity
Hypertension7890 (29.3)868 (28.4)1721 (46.8)2589 (38.4)<0.001
Diabetes2358 (8.75)298 (9.73)541 (14.7)839 (12.5)<0.001
Hyperlipidaemia5354 (19.9)656 (21.4)1450 (39.5)2106 (31.3)<0.001
CAD3573 (13.3)434 (14.2)1224 (33.3)1658 (24.6)<0.001
Heart failure728 (2.70)56 (1.83)217 (5.91)273 (4.05)<0.001
Cancer640 (2.38)71 (2.32)156 (4.25)227 (3.37)<0.001
Stroke855 (3.17)77 (2.51)222 (6.04)299 (4.44)<0.001
Low leg fracture or surgery580 (2.15)48 (1.57)126 (3.43)174 (2.58)0.03
  • *Two-sample t-test.

  • CAD, coronary artery disease.